Metformin, estrogen replacement therapy and gonadotropin inhibition fail to improve insulin sensitivity in a girl with aromatase deficiency

Hormone Research

Volumn 72, Issue 6, 2009, Pages 370-376

  Guercio, Gabriela ^a   Di Palma, Maria Isabel ^a   Pepe, Carolina ^a   Saraco, Nora I ^a   Prieto, Mariana ^a   Saure, Carola ^a   Mazza, Carmen ^a   Rivarola, Marco A ^a   Belgorosky, Alicia ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Androgen excess; Aromatase deficiency; Estrogen replacement; Insulin insensitivity; Metabolic syndrome

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CONJUGATED ESTROGEN; FOLLITROPIN; GONADOTROPIN; METFORMIN; TESTOSTERONE; TRIPTORELIN;

ACANTHOSIS NIGRICANS; ADOLESCENT; ANDROGEN BLOOD LEVEL; AROMATASE DEFICIENCY; ARTICLE; CASE REPORT; DRUG DOSE INCREASE; ENZYME DEFICIENCY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; GLUCOSE INTOLERANCE; GONADOTROPIN BLOOD LEVEL; HORMONE INHIBITION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TREATMENT FAILURE;

ANDROGEN ANTAGONISTS; ANDROGENS; AROMATASE; CHILD; DIABETES MELLITUS, TYPE 2; ESTROGEN REPLACEMENT THERAPY; FEEDBACK, PHYSIOLOGICAL; FEMALE; FETUS; GONADOTROPIN-RELEASING HORMONE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; METFORMIN; PREGNANCY;

EID: 70350046653     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000249165     Document Type: Article

References (32)

1. Belgorosky A, Rivarola MA: Physiology and pathophysiology of estrogens. Lessons from pediatric patients with complete aromatase deficiency. Endocrinologist 2004; 14: 1-8.
2. Jones M, Thorburn A, Britt K, Hewitt K, Wreford N, Proietto J, Oz O, Leury B, Robertson K, Yao S, Simpson ER: Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 2000; 97: 12735-12740.
3. Takeda K, Toda K, Saibara T, Nakagawa M, Saika K, Onishi T, Sugiura T, Shizuta Y: Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 2003; 17: 237-246.
4. Fisher CR, Graves KH, Parlow AF, Simpson ER: Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the CYP19 gene. Proc Natl Acad Sci USA 1998; 95: 6965-6970.
5. Britt KL, Drummond AE, Cox VA, Dyson M, Wreford NG, Jones ME, Simpson ER, Findlay JK: An age-related ovarian phenotype in mice with targeted disruption of the CYP19 (aromatase) gene. Endocrinology 2000; 141: 2614-2623.
6. Lin L, Ercan O, Raza J, Burren CP, Creighton SM, Auchus RJ, Dattani MT, Achermann JC: Variable phenotypes associated with aromatase (CYP19) insufficiency in humans. J Clin Endocrinol Metab 2007; 92: 982-990.
7. Pepe C, Saraco, Baquedano S, Guercio G, Vaiani E, Marino R, Pandey A, Flück C, Rivarola MA, Belgorosky A: The cytochome P450 aromatase lacking exon 5 is associated with a phenotype of non-classic aromatase deficiency, and it is also present in normal human steroidogenic tissues. Clin Endocrinol (Oxf) 2007; 67: 698-705.
8. Belgorosky A, Pepe C, Marino R, Guercio G, Saraco N, Vaiani E, Rivarola MA: Hypothalamic- pituitary-ovarian axis during infancy, early and late prepuberty in an aromatasedeficient girl who is a compound heterozygote for two new point mutations of the CYP19 gene. J Clin Endocrinol Metab 2003; 88: 5127-5131.
9. Ludwig M, Beck A, Wickert L, Bolkenius U, Tittel B, Hinkel K, Bidlingmaier F: Female pseudohermaphroditism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene. J Pediatr Endocrinol Metab 1998; 11: 657-664.
10. Mullis PE, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H: Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab 1997; 82: 1739-1745.
11. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K: Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995; 80: 3689-3698.
12. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER: A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 1994; 78: 1287-1292.
13. Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER: Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA 1993; 90: 11673-11677.
14. Shozu M, Akasofu K, Harada T, Kubota Y: A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab 1991; 72: 560-566.
15. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, Clyne C, Davis S, Simpson ER, Carani C: Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate and estradiol treatment. J Clin Endocrinol Metab 2004; 89: 61-70.
16. Herrmann BL, Saller B, Janssen OE, Gocke P, Bockisch A, Sperling H, Mann K, Broecker M: Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab 2002; 87: 5476-5484.
17. Deladoey J, Fluck C, Bex M, Yoshimura N, Harada N, Mullis PE: Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy. J Clin Endocrinol Metab 1999; 84: 4050-4054.
18. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER: Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997; 337: 91-95.
19. Herrmann BL, Janssen OE, Hahn S, Broecker- Preuss M, Mann K: Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency. Horm Metab Res 2005; 37: 178-183.
20. Puavilai G, Chanprasertyotin S, Sriphrapradaeng A: Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. Diabetes Res Clin Pract 1999; 44: 21-26.
21. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331: 1056-1061. Erratum in: N Engl J Med 1995; 332: 131.
22. Jones M, Boom W, Proietto J, Simpson ER: Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab 2006; 17: 53-62.
23. Ryan AS, Nicklas BJ, Berman DM: Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care 2002; 25: 127-133.
24. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 2004; 19: 41-47.
25. Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP: Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab 2002; 87: 2114-2120.
26. Friedl KE, Jones RE, Hannan CJ Jr, Plymate SR: The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance. J Clin Endocrinol Metab 1989; 68: 971-975.
27. Eisner JR, Dumesic DA, Kemnitz JW, Abbott DH: Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab 2000; 85: 1206-1210.
28. Dumesic DA, Abbott DH, Eisner JR, Goy RW: Prenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood. Fertil Steril 1997; 67: 155-163.
29. Franks S: Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-861.
30. Unlühizarci K, Ozocak M, Tanriverdi F, Atmaca H, Kelestimur F: Investigation of hypothalamo- pituitary-gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystic ovary syndrome. Fertil Steril 2007; 87: 1377-1382.
31. Hewitt KN, Boon WC, Murata Y, Jones ME, Simpson ER: The aromatase knockout mouse presents with a sexually dimorphic disruption to cholesterol homeostasis. Endocrinology 2003; 144: 3895-3903.
32. Hewitt KN, Pratis K, Jones ME, Simpson ER: Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 2004; 145: 1842-1848.